← FDA DRUG APPROVALS

FDA ANDA · ANDA090685

PURELAX

polyethylene glycol 3350

Sponsor: PPI-DAC

APPLICATION
ANDA090685
TYPE
ANDA
ORIGINAL APPROVAL
2009-10-06
LATEST ACTION
2022-06-16
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Over-the-counter

Products

POLYETHYLENE GLYCOL 3350Over-the-counter
POLYETHYLENE GLYCOL 3350 17GM/PACKET · FOR SOLUTION · ORAL
POLYETHYLENE GLYCOL 3350Over-the-counter
POLYETHYLENE GLYCOL 3350 17GM/SCOOPFUL · FOR SOLUTION · ORAL

Approval history

2022-06-16Manufacturing (CMC) · Supplement 14 · unknownAP
2021-10-13Labeling · Supplement 13 · standardAP
2021-10-13Labeling · Supplement 11 · standardAP
2019-10-11Manufacturing (CMC) · Supplement 9 · unknownAP
2016-01-12Labeling · Supplement 3 · standardAP
2013-02-06Labeling · Supplement 2AP
2009-10-06OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →